186 related articles for article (PubMed ID: 15472596)
1. Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction?
Lloyd GM; Newton JD; Norwood MG; Franks SC; Bown MJ; Sayers RD
J Vasc Surg; 2004 Oct; 40(4):691-7. PubMed ID: 15472596
[TBL] [Abstract][Full Text] [Related]
2. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
3. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
Corp EV; Antoniou S; Wright PG; Khachi H; Vercaeren S; Wald DS
QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
[TBL] [Abstract][Full Text] [Related]
4. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
5. Peripheral arterial disease and abdominal aortic aneurysm in elderly people.
Aronow WS
Minerva Med; 2011 Dec; 102(6):483-500. PubMed ID: 22193380
[TBL] [Abstract][Full Text] [Related]
6. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
Barski L; Porath A; Novack V; Jotkowitz A
Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
[TBL] [Abstract][Full Text] [Related]
8. Peripheral arterial disease: a review of disease awareness and management.
Watson K; Watson BD; Pater KS
Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
[TBL] [Abstract][Full Text] [Related]
9. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
Sigvant B; Henriksson M; Lundin F; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
[TBL] [Abstract][Full Text] [Related]
11. [Medical treatment of small abdominal aortic aneurysms].
Høgh AL; Sandermann J; Lindholt JS
Ugeskr Laeger; 2008 Jun; 170(23):2003-5. PubMed ID: 18534161
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
Joseph J; Koka M; Aronow WS
J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
[TBL] [Abstract][Full Text] [Related]
13. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
[TBL] [Abstract][Full Text] [Related]
14. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
15. Medical management of abdominal aortic aneurysm.
Golledge J; Powell JT
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):267-73. PubMed ID: 17540588
[TBL] [Abstract][Full Text] [Related]
16. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
17. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.
Henke PK; Blackburn S; Proctor MC; Stevens J; Mukherjee D; Rajagopalin S; Upchurch GR; Stanley JC; Eagle KA
J Vasc Surg; 2004 Feb; 39(2):357-65. PubMed ID: 14743136
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
19. Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair.
Kurzencwyg D; Filion KB; Pilote L; Nault P; Platt RW; Rahme E; Steinmetz O; Eisenberg MJ
Ann Vasc Surg; 2006 Sep; 20(5):569-76. PubMed ID: 16794911
[TBL] [Abstract][Full Text] [Related]
20. Growth predictors and prognosis of small abdominal aortic aneurysms.
Schlösser FJ; Tangelder MJ; Verhagen HJ; van der Heijden GJ; Muhs BE; van der Graaf Y; Moll FL;
J Vasc Surg; 2008 Jun; 47(6):1127-33. PubMed ID: 18440183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
